Target Price | $135.19 |
Price | $131.34 |
Potential |
2.93%
register free of charge
|
Number of Estimates | 24 |
24 Analysts have issued a price target Novartis ADR 2026 .
The average Novartis ADR target price is $135.19.
This is
2.93%
register free of charge
$158.30
20.52%
register free of charge
$101.51
22.71%
register free of charge
|
|
A rating was issued by 32 analysts: 13 Analysts recommend Novartis ADR to buy, 15 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Novartis ADR stock has an average upside potential 2026 of
2.93%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 51.72 | 56.41 |
10.85% | 9.06% | |
EBITDA Margin | 31.96% | 41.45% |
14.24% | 29.70% | |
Net Margin | 23.09% | 31.14% |
27.46% | 34.88% |
23 Analysts have issued a sales forecast Novartis ADR 2025 . The average Novartis ADR sales estimate is
This results in the following potential growth metrics:
18 Analysts have issued an Novartis ADR EBITDA forecast 2025. The average Novartis ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
24 Novartis ADR Analysts have issued a net profit forecast 2025. The average Novartis ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 5.87 | 9.07 |
17.21% | 54.51% | |
P/E | 14.47 | |
EV/Sales | 4.87 |
24 Analysts have issued a Novartis ADR forecast for earnings per share. The average Novartis ADR EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Locked
➜
Locked
|
Locked | Sep 16 2025 |
GUGGENHEIM SECURITIES LLC |
Locked
➜
Locked
|
Locked | Sep 09 2025 |
DAY BY DAY |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
JEFFERIES |
Locked
➜
Locked
|
Locked | Sep 02 2025 |
TD COWEN |
Locked
➜
Locked
|
Locked | Aug 12 2025 |
INTESA SANPAOLO EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
LANDESBANK BADEN-WUERTTEMBERG |
Locked
➜
Locked
|
Locked | Jul 23 2025 |
Analyst Rating | Date |
---|---|
Locked
BERENBERG:
Locked
➜
Locked
|
Sep 16 2025 |
Locked
GUGGENHEIM SECURITIES LLC:
Locked
➜
Locked
|
Sep 09 2025 |
Locked
DAY BY DAY:
Locked
➜
Locked
|
Sep 08 2025 |
Locked
JEFFERIES:
Locked
➜
Locked
|
Sep 02 2025 |
Locked
TD COWEN:
Locked
➜
Locked
|
Aug 12 2025 |
Locked
INTESA SANPAOLO EQUITY RESEARCH:
Locked
➜
Locked
|
Aug 08 2025 |
Locked
LANDESBANK BADEN-WUERTTEMBERG:
Locked
➜
Locked
|
Jul 23 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.